The Iraqi BC risk was associated with the RAD51 (G>T) polymorphism. GT genotype / T allele patients responded well to RT, indicating that RAD51 might predict cancer risk and RT effectiveness. Iraqi women may benefit from the RAD51 (G>C) GG genotype in protection against BC.
Abbas et al. (2026) studied this question.